期刊文献+

软组织肉瘤补充广泛切除术的疗效分析 被引量:3

Secondary radical excision of soft tissue sarcoma
下载PDF
导出
摘要 目的探讨补充广泛切除术在软组织肉瘤外科治疗中的意义。方法回顾性分析1998年1月至2005年10月收治的外院误诊为良性肿瘤而行局部切除的软组织肉瘤患者58例,均行补充广泛切除手术治疗。结果术后病理标本切除缘评价5cm者14例;3cm者32例;3cm以下者12例。首次术后肿瘤残存26例,占45%。补充广泛切除术后有28例需要行软组织修复重建。补充广泛切除手术后随诊10~94个月,8例复发,12例转移,死亡9例。均为高度恶性软组织肉瘤。Kaplan-Meier法计算5年生存率为84.5%,局部复发率为14%。切除缘的5年生存率3cm以上组和3cm以下组之间无显著性差异。局部复发率3cm以上组和3cm以下组有显著性差异(P<0.05)。结论补充广泛切除术是误诊软组织肉瘤最主要的治疗手段,补充广泛切除的标准切除缘的制定是今后的研究课题。缩小切除缘,可以改善预后,减少组织缺损所造成的修复重建。 Objective To investigate the curative effect of secondary radical excision after inadequate treatment of soft tissue sarcoma. Methods 58 patients with soft tissue sarcoma were retrospectively analyzed. All these patients were diagnosed as benign lesions before primary surgery and proved malignant postoperatively. Results There were 26 cases with tumor remaining after the first operation (45%). After secondary radical excision, the recurrence was in 8 and metastasis in 12 and death in 9 at the duration of 10 to 94 months. 5-year- survival rate were 84.5% and the recurrence rate were 14%. Conclusions Secondary radical excision is the major important factor for the treatment of prior under-treatment soft tissue sarcoma. Reducing the range of excision can improve the prognosis and lessen the rate of reconstruct.
出处 《中国骨肿瘤骨病》 2007年第4期193-195,共3页 Chinse Journal Of Bone Tumor And Bone Disease
关键词 软组织肉瘤 手术切除 复发 Soft tissue sarcoma Surgery Recurrence
  • 相关文献

参考文献7

  • 1[1]Siebenrock KA,Hertel R,Ganz R.Un-expected resection of soft-tissue sarcoma; more mutilating surgery,higher local recur-rence rates,and obscure prognosis as cones-quences of improper surgery.Arch Orthop Trauma Surg,20001,20:65-69.
  • 2[2]Gustafson P,Dreinhofer KE,Rydholm A.Softtissue sarcoma should be treated at a tumor center; a comparison of quality of surgery in 375 patienta.Acta Orthop Scand,1994,65:47-50.
  • 3[3]Singer S,Conrson JM,Gonin R,et al.Prognostic factors predictive of survival and localrecurrebce for extremity softtissue sarcoma.Ann Surg,1995,219:165-173.
  • 4[4]Zornig C,Peiper M,Schroder S.Re-excision of soft tissue sarcoma after inadequate initial operation.Br J Surg,1995,82:278-279.
  • 5[5]Goodlad JR,Fletcher CD,Smith MA.Surgical resection of primary soft-tissue sarcoma; incidence of residual tumour in 95 patients needing re-excision after local resection.J Bone Joint Surg,1997,79-B:171-172.
  • 6[6]Noria S,Davis A,Kandel R,et al.Residual disease following unplanned excision of soft-tissue sarcoma of an extremity.J Bone Joint Surg,1996,78-A:639-643.
  • 7[7]Lewis JJ,Leung D,Espat J,et al.Effect of reresection in extremity soft tissue sarcoma.Ann Surg,2000,231:655-663.

同被引文献40

  • 1Enzinger FM. Clear-cell sarcoma of tendons and aponeuroses: an analysis of 21 eases [J]. Cancer, 1965, 18:1163-1174.
  • 2Chung EB, Enzinger FM. Malignant melanoma of soft parts: a reassessment of clear cell sarcoma [J]. Am J Surg Pathol, 1983, 7: 405-413.
  • 3Zueman J, Delattre O, Desmaze C, et al. EWS and ATF-1 gene fusion induced by t(12;22) traaslocation in malignant melanoma of soft parts[J].Nat Genet, 1993, 4:341-345.
  • 4Langezaal SM, Graadt van Roggen JF, Cleton-Jansen AM, et al. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts) [J]. Br J Cancer; 2001, 84:535-538.
  • 5Panagopoulos I, Mertens F, Debiec-Rychter M, et al. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses [J]. Int J Cancer, 2002, 99:560-567.
  • 6Antonescu CR, Tschernyavsky S J, Woodruff JM, et al. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathologieal and ultrastructural analysis of 12 cases [J]. J Mol Diagn, 2002, 4:44-52.
  • 7Lueas DR, Naseimento AG, Sim FH. Clear cell sarcoma of soft tissues: Mayo Clinic experience with 35 eases [J]. Am J Surg Pathol, 1992, 16:1197-1204.
  • 8Montgomery EA, Meis JM, Ramos AG, et al. Clear cell sarcoma of tendons and aponeuroses: a clinicopathologic study of 58 cases with analysis of prognostic factors [J]. Int J Surg Pathol, 1993, 1:89-100.
  • 9Ferrari A, Casanova M, Bisogno G, et al. Clear cell sarcoma of tendons and aponeuroses in pediatric patients: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group [J]. Cancer, 2002, 94:3269-3276.
  • 10AI-Refaie WB, Ali MW, Chu DZ, et al. Clear cell sarcoma in the era of sentinel lymph node mapping [J]. J Surg Oncol, 2004, 87:126-129.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部